Provided by Tiger Trade Technology Pte. Ltd.

McKesson

891.68
+2.560.29%
Post-market: 891.800.1168+0.01%19:30 EDT
Volume:972.38K
Turnover:867.23M
Market Cap:104.40B
PE:23.79
High:897.51
Open:889.25
Low:880.27
Close:889.12
52wk High:999.00
52wk Low:687.68
Shares:117.08M
Float Shares:117.08M
Volume Ratio:1.19
T/O Rate:0.83%
Dividend:3.28
Dividend Rate:0.37%
EPS(TTM):37.48
EPS(LYR):38.38
ROE:1401.75%
ROA:4.74%
PB:-24.62
PE(LYR):23.23

Loading ...

Sweden's Biovica Q1 Sales Rise on Pharma Services Growth

Reuters
·
Yesterday

McKesson Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

McKesson Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

BCE Names Rebecca McKillican to Board

Reuters
·
Sep 03

Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating

MT Newswires Live
·
Sep 03

McKesson Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

McKesson Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Mckesson Corp Stock (MCK) Moved Up by 3.13% on Sep 1: Key Drivers Unveiled

TradingKey
·
Sep 02

Prabowo Chairs Limited Meeting on Affordable, Decent Housing

Tempo
·
Sep 01

McKesson Reports Cyberattack

Dow Jones
·
Aug 29

McKesson Reports Cybersecurity Incident

MT Newswires Live
·
Aug 29

McKesson announces cybersecurity incident, investigation in early stages

TIPRANKS
·
Aug 29

Mckesson Corp - Discovers Cybersecurity Incident Affecting Information Systems on August 25, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 29

McKesson Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Mckesson Corp Stock (MCK) Moved Up by 3.25% on Aug 25: What Signal Does It Send?

TradingKey
·
Aug 26

Movement Alert|McKesson Rises 3.02% in Regular Trading, Announces Approximately $2.25 Billion Acquisition of Precision Medicine Group

Market Focus
·
Aug 26

McKesson Buy Rating Reiterated as Precision Medicine Acquisition Expands Oncology Strategy; Price Target Maintained at $977

TIPRANKS
·
Aug 26

Morgan Stanley views Precision Medicine as logical addition to McKesson platform

TIPRANKS
·
Aug 26

McKesson Buy Rating Reiterated as Precision Medicine Acquisition Strengthens Oncology Platform; $1050 Price Target Unchanged

TIPRANKS
·
Aug 25

McKesson signs agreement to acquire Precision Medicine Group

TIPRANKS
·
Aug 25